NERVIGESIC 75 CAP is a formulation of Pregabalin 75 mg, designed for the management of neuropathic pain, fibromyalgia, and anxiety disorders. It acts on nerve signals in the brain and spinal cord, offering effective relief from chronic pain and helping to improve sleep and overall quality of life.

This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.

NERVIGESIC 75 CAP contains Pregabalin 75 mg, a powerful and well-researched medication primarily used to manage neuropathic pain associated with diabetic peripheral neuropathy, post-herpetic neuralgia, spinal cord injuries, and fibromyalgia. It is also widely used for generalized anxiety disorder and as an adjunct therapy for partial seizures.

Pregabalin, the active ingredient in NERVIGESIC 75 CAP, works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This action reduces the release of excitatory neurotransmitters such as glutamate, noradrenaline, and substance P, leading to decreased nerve signal transmission and relief from persistent pain. The mechanism not only helps alleviate physical symptoms but also improves sleep quality and emotional stability, making it a comprehensive treatment for patients with chronic pain and associated disorders.

NERVIGESIC 75 CAP is especially effective for patients who experience burning, tingling, or shooting pains, commonly observed in nerve-related conditions. It helps in interrupting the pain signals and calming overactive nerves without affecting normal nerve function.

This product is manufactured by Bluepill Express under WHO-GMP and ISO-certified facilities, adhering to stringent quality control standards. The formulation is presented in easy-to-swallow, moisture-resistant hard gelatin capsules that ensure stability, efficacy, and excellent patient compliance. Its convenient dosing and reliable therapeutic action make it a preferred choice among healthcare providers.

NERVIGESIC 75 CAP is suitable for once or twice daily dosing depending on the patient’s medical requirement. It is commonly started at a lower dose and gradually titrated based on tolerance and therapeutic response. This approach minimizes common side effects such as dizziness, somnolence, and mild weight gain, which are usually transient.

As a part of chronic pain management therapy, NERVIGESIC 75 CAP improves mobility, mental focus, and sleep patterns, enabling patients to resume daily activities with improved physical and psychological well-being. It is particularly useful in long-term therapy where maintaining consistent pain relief with minimal side effects is crucial.